Related Experiment Videos
Constitutional and acquired trisomy 8
L M Secker-Walker1, M Fitchett
1Department of Haematology, Royal Free Hospital School of Medicine, London, U.K.
Leukemia Research
|October 1, 1995
Summary
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients.
Leukemia & lymphoma·2016
Same author
Prenatal diagnosis of cri du chat (5p-) syndrome in association with isolated moderate bilateral ventriculomegaly.
Prenatal diagnosis·2002
Same author
The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management.
British journal of haematology·2001
Same author
Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia.
Leukemia·2000
Same author
Investigation of clonal involvement of myeloid cells in Philadelphia-positive and high hyperdiploid acute lymphoblastic leukemia.
Leukemia·1999
Same journal
Multispecialty referral patterns to a clonal hematopoiesis clinic: Who, what, and why?
Leukemia research·2026
Same journal
A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.
Leukemia research·2026
Same journal
FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.
Leukemia research·2026
Same journal
CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.
Leukemia research·2026
Same journal
Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.
Leukemia research·2026
Same journal
Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.
Leukemia research·2026